A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Carbuncosis pulmonar
Hay disponibilidad de una vacuna contra el carbunco para personal militar seleccionado de los Estados Unidos, pero no para el público general.
A las personas que han estado realmente expuestas al carbunco, pero que no presentan signos ni síntomas de la enfermedad, se les puede suministrar antibióticos preventivos.
No se conocen casos de transmisión del carbunco de una persona a otra. Las personas que viven con individuos con carbunco no requieren antibióticos, a menos que también hayan estado expuestas a la misma fuente de esta enfermedad.
Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a Biological Weapon, 2002. JAMA.160;2002;287:2236-2252.
Lucey DR. Anthrax. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier. 2007: chap 317.
Reissman DB, Whitney EA, Taylor TH Jr, et al. One-Year Health Assessment of Adult Survivors of Bacillus anthracis Infection.JAMA. 2004;291:1994-1998.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885